Chemidarou Industrial Company
Chemidarou Industrial Company
Chemidarou Industrial Company is a listed Tehran-based pharmaceutical manufacturer with a long operating history and a broad product portfolio across common therapeutic classes. In the Hormuz Group company graph, it matters because it connects domestic medicine manufacturing, raw-material imports, regulated pricing, pharmacy demand, distribution networks, and healthcare supply stability. Its listed status makes it useful for monitoring pharmaceutical margins, product mix, disclosure quality, and exposure to imported active ingredients.
Products & Services
Chemidarou Industrial Company manufactures pharmaceutical products in forms including ampoules, tablets, capsules, drops, suspensions, and supplements. Its therapeutic coverage includes painkillers, cardiovascular, anti-diabetic, anti-fungal, digestive, antibiotic, antihistamine, rheumatology, anti-gout, urology, neuropsychiatric, and food-supplement categories.
Investment Relevance
Chemidarou is relevant for investors assessing Iran's listed pharmaceutical sector, domestic drug production, therapeutic diversification, import dependence for APIs and excipients, and pricing regulation. It can support analysis of medicine shortages, production resilience, distributor payment cycles, regulatory reimbursement, and the ability of local manufacturers to substitute imported finished drugs. Due diligence should review current financial disclosures, product registrations, GMP status, raw-material sourcing, export channels, energy and packaging costs, receivables, and shareholder or holding-company relationships.
Connected Intelligence
This profile is connected to Hormuz taxonomy layers across geography, industry, market exposure, and investment constraints.
Source & Verification Note
Based on public company, official-company, pharmaceutical-sector, market, and disclosure-related information. Further verification is required before treating this profile as verified investment intelligence.